scorecardresearch
Thursday, July 24, 2025
TopicCovid vaccines

Topic: Covid vaccines

DCGI gives emergency use approval to Biological E’s Corbevax vaccine for kids aged 12-18

It is the second Covid vaccine to get approval for use in children in India after Bharat Biotech's Covaxin.

Covaxin supplies, trial group size — why there’s a delay in Covid vaccine for younger kids

Monthly Covaxin output between 5.5-6.5 cr. Country needs at least 15 cr doses for full coverage 15-18 age group. Choice of 6 μg dose reduced manufacturing capacity, says Bharat Biotech.

Over 70% children aged 15-18 yrs received first dose of Covid vaccine, says Mansukh Mandaviya

Health minister Mandaviya says 1.47 crore beneficiaries in the 15-18 age group are fully vaccinated and appealed to all eligible children to get inoculated at the earliest.

ZyCov-D a welcome addition to India’s vaccine basket. Follow the science on mixing boosters now

ThePrint view on the most important issues, instantly.

Covid response has generated thousands of tonnes of extra medical waste in health threat: WHO

To get a sense of the scope of the issue, WHO examined the fate of 87,000 metric tonnes of PPE that were shipped via a UN initiative between March 2020 and November 2021.

Corbevax, a new patent-free Covid vaccine, is an important step to end pandemic

Corbevax was developed with global vaccine access in mind. The goal was to make a low-cost, easy-to-produce and -transport vaccine.

More than Wang Yi’s remark, India should worry about the proposal for a new island nations’ forum

ThePrint view on the most important issues, instantly.

Paracetamol, pain killers not recommended for children after Covaxin shot, says Bharat Biotech

Covaxin makers said most reported side effects are mild & 'resolve within 1-2 days, and do not require medication'. So far Covaxin is only Covid vaccine available for 15-18 year olds in India.

Over 41 lakh teens take first Covid shot as India opens up vaccination for young adults

PM Modi had announced on 25 December that adolescents above the age of 15 will be able to take their vaccines from 3 January. The campaign began Monday.

Cipla gets drug regulator’s nod to market Molnupiravir for Covid treatment

Earlier in the year, Cipla entered into a licensing agreement with Merck Sharpe Dohme to make and supply Molnupiravir in India and to over 100 low and middle-income countries.

On Camera

TV Somanathan’s letter is a reminder—civil servants must roll out the red carpet for investors

The reason that India hasn’t grown at the speed of South Korea, China or Vietnam is because the machinery of the government still holds on to the ‘commanding heights’.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Indian firm sets up titanium, superalloy plants to meet global need. Safran, Dassault, BAE line up

PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.